pyruvaldehyde has been researched along with Coronary Heart Disease in 3 studies
Pyruvaldehyde: An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals.
methylglyoxal : A 2-oxo aldehyde derived from propanal.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| de la Cruz-Ares, S | 1 |
| Cardelo, MP | 2 |
| Gutiérrez-Mariscal, FM | 2 |
| Torres-Peña, JD | 1 |
| García-Rios, A | 1 |
| Katsiki, N | 1 |
| Malagón, MM | 1 |
| López-Miranda, J | 2 |
| Pérez-Martínez, P | 2 |
| Yubero-Serrano, EM | 2 |
| de la Cruz, S | 1 |
| Alcala-Diaz, JF | 1 |
| Roncero-Ramos, I | 1 |
| Guler, I | 1 |
| Vals-Delgado, C | 1 |
| López-Moreno, A | 1 |
| Luque, RM | 1 |
| Delgado-Lista, J | 1 |
| Navarrete Santos, A | 1 |
| Jacobs, K | 1 |
| Simm, A | 1 |
| Glaubitz, N | 1 |
| Horstkorte, R | 1 |
| Hofmann, B | 1 |
2 trials available for pyruvaldehyde and Coronary Heart Disease
| Article | Year |
|---|---|
Endothelial Dysfunction and Advanced Glycation End Products in Patients with Newly Diagnosed Versus Established Diabetes: From the CORDIOPREV Study.
Topics: Biomarkers; Carotid Artery Diseases; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus, T | 2020 |
Reduction in Circulating Advanced Glycation End Products by Mediterranean Diet Is Associated with Increased Likelihood of Type 2 Diabetes Remission in Patients with Coronary Heart Disease: From the Cordioprev Study.
Topics: Antigens, Neoplasm; Coronary Disease; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Diet, Mediter | 2021 |
1 other study available for pyruvaldehyde and Coronary Heart Disease
| Article | Year |
|---|---|
Dicarbonyls induce senescence of human vascular endothelial cells.
Topics: Cellular Senescence; Coronary Disease; Cyclin-Dependent Kinase Inhibitor p21; Endothelial Cells; Gly | 2017 |